AUSAF (Australis Capital) Days Sales Outstanding: (As of Mar. 2022)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Australis Capital Days Sales Outstanding?

Australis Capital's average Accounts Receivable for the three months ended in Mar. 2022 was $0.00 Mil. Australis Capital's Revenue for the three months ended in Mar. 2022 was $3.18 Mil. Hence, Australis Capital's Days Sales Outstanding for the three months ended in Mar. 2022 was 0.00.

The historical rank and industry rank for Australis Capital's Days Sales Outstanding or its related term are showing as below:

AUSAF's Days Sales Outstanding is not ranked *
in the Drug Manufacturers industry.
Industry Median: 71.98
* Ranked among companies with meaningful Days Sales Outstanding only.

Australis Capital's Days Sales Outstanding stayed the same from Mar. 2021 () to Mar. 2022 ().

Australis Capital  (OTCPK:AUSAF) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Australis Capital Days Sales Outstanding Related Terms

Australis Capital Days Sales Outstanding Historical Data

* Premium members only.

The historical data trend for Australis Capital's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Australis Capital Days Sales Outstanding Chart

Australis Capital Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22
Days Sales Outstanding
Get a 7-Day Free Trial - - - - -

Australis Capital Quarterly Data
Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22
Days Sales Outstanding Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

AUSAF vs ZTS, CTLT, VTRS: Days Sales Outstanding Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Australis Capital's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Australis Capital Days Sales Outstanding vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Australis Capital's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Australis Capital's Days Sales Outstanding falls into.


Australis Capital Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Australis Capital's Days Sales Outstanding for the fiscal year that ended in Mar. 2022 is calculated as

Days Sales Outstanding (A: Mar. 2022 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Mar. 2021 ) + Accounts Receivable (A: Mar. 2022 )) / count ) / Revenue (A: Mar. 2022 )*Days in Period
=( ( + ) / 1 ) / 7.5562028212252*365
=0 / 7.5562028212252*365
=0.00

Australis Capital's Days Sales Outstanding for the quarter that ended in Mar. 2022 is calculated as:

Days Sales Outstanding (Q: Mar. 2022 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2021 ) + Accounts Receivable (A: Mar. 2022 )) / count ) / Revenue (A: Mar. 2022 )*Days in Period
=( ( + ) / 1 ) / 3.1751732713573*365 / 4
=0 / 3.1751732713573*365 / 4
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Australis Capital Business Description

Address 376 E. Warm Springs Road, Suite 190, Las Vegas, NV, USA, 89119
Australis Capital Inc operates as a multi-state operator in the cannabis industry in the US. The company is focused on brands and attractive cannabis licenses in states with favorable economics. AUSA is building an MSO based on a unique and very difficult to imitate strategy. Secure access to low-cost but high-quality biomass enables the company to fuel the expansion of its footprint across the US. The company has a rapidly growing footprint in the U.S. in states, such as California, Nevada, Massachusetts, Missouri, Oklahoma, as well as international operations through its subsidiary ALPS, with projects in Europe, Asia and North America.